Fredrik Lindberg - Enzymatica Publ Chief Executive Officer

Mr. Fredrik Lindberg was appointed Chief Executive Officer of Enzymatica AB effective as of February 16, 2015. He no longer serves as Independent Chairman of the Board of Directors at Enzymatica AB, effective as of February 15, 2015. He has held this position since September 9, 2014. He was Independent Member of the Board of the Company since February 2012. He is Certified Medical Doctor and Docent in Clinical Pharmacology. He is CoFounder of BoneSupport AB. He is Member of the Board of Enzymatica Care AB, Fiddevangen Aktiebolag and Deputy Board Member of Bone Support Incentive AB as well as Senior Advisor in Bone Support AB. Previously, he was Member of the Board and Chief Executive Officer of Ultrazonix DNT AB, Ultrazonix Holding AB, BoneSupport AB and Bonesupport Holding AB, as well as Member of the Board of MedArt AS and Chief Executive Officer of GMF Fastighetsaktiebolag. He was recently Chief Scientific Officer at BoneSupport AB. He also served as Nordic Medical Director at Searle Pharmaceuticals, Chief Physician at Department for Clinical Pharmacolgy at University Hospital in Lund. He has knowledge of the pharmaceutical, fundraising and medical research, and global sales. He received the Entrepreneur of the Year award at Ideon Science Park in Lund in 2011. since 2015.